SAREPTA THERAPEUTICS INC. - COMMON STOCK
133.98
03-五月-24 14:29:19
15 分钟延时
股票
+3.35
+2.56%
今日范围
131.16 - 134.39
ISIN
N/A
来源
NASDAQ
-
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
31 8月 2022 17:59:49 条件 Nasdaq GlobeNewswire
-
02 8月 2022 16:05:01 条件 Nasdaq GlobeNewswire
-
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
29 7月 2022 18:25:00 条件 Nasdaq GlobeNewswire
-
29 7月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
26 7月 2022 08:30:00 条件 Nasdaq GlobeNewswire
-
06 7月 2022 08:15:00 条件 Nasdaq GlobeNewswire
-
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
30 6月 2022 18:15:41 条件 Nasdaq GlobeNewswire
-
Sarepta Therapeutics Provides Update on SRP-5051 for the Treatment of Duchenne Muscular Dystrophy
23 6月 2022 16:01:00 条件 Nasdaq GlobeNewswire
-
Sarepta Therapeutics Appoints Michael Chambers and Kathryn Boor, Ph.D., to Its Board of Directors
02 6月 2022 16:05:00 条件 Nasdaq GlobeNewswire
-
Sarepta Therapeutics to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference
02 6月 2022 08:30:00 条件 Nasdaq GlobeNewswire
-
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
31 5月 2022 18:15:23 条件 Nasdaq GlobeNewswire
-
04 5月 2022 16:05:04 条件 Nasdaq GlobeNewswire
-
Sarepta Therapeutics to Present at the BofA Securities 2022 Healthcare Conference
04 5月 2022 08:30:00 条件 Nasdaq GlobeNewswire
-
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
29 4月 2022 18:23:39 条件 Nasdaq GlobeNewswire
-
27 4月 2022 08:30:00 条件 Nasdaq GlobeNewswire
-
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
31 3月 2022 18:30:47 条件 Nasdaq GlobeNewswire
-
Sarepta Therapeutics to Present at Upcoming Investor Conferences
02 3月 2022 16:30:00 条件 Nasdaq GlobeNewswire
-
01 3月 2022 16:05:02 条件 Nasdaq GlobeNewswire